← Eichor
Study identifier: NCT05457283 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Condition: Chronic Kidney Disease · Proteinuria · Children  ·  Sponsor: Bayer

PhasePhase 3
Planned participants100
Who can joinAll sexes, 1 Year to 18 Years
Healthy volunteersNo

About this study

Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine. The kidneys filter waste and fluid from the blood to form urine. In children with CKD, the kidney´s filters do not work as well as they should. This can lead to accumulation of waste and fluid in the body and proteinuria. CKD can lead to other medical problems, such as high blood pressure, also known as hypertension. Vice versa, hypertension and proteinuria can also contribute to worsening of CKD. Therefore, the treatment of CKD aims to control blood pressure and proteinuria. There are treatments available for doctors to prescribe to children with CKD and hypertension and/or proteinuria. These include "angiotensin-converting enzyme inhibitors" (ACEI) and "angiotensin receptor blockers" (ARB). Both ACEI and ARB can help improve kidney function by reducing the activity of the renin-angiotensin-aldosterone system (RAAS). The RAAS is a system that works with the kidneys to control blood pressure and the balance of fluid and electrolytes in the blood. In people with CKD, the RAAS is often too active, which can impair the ability of the kidneys to work properly and cause hypertension and proteinuria. However, ACEI or ARB treatment alone does not work for all patients with CKD as they only target the angiotensin part of the renin-angiotensin-aldosterone system. The …

This description comes directly from the study's public registry record.

Talk to the study team

Bayer Clinical Trials Contact  ·  (+)1-888-84 22937  ·  clinical-trials-contact@bayer.com

Always discuss trial participation with your own doctor first.

Locations (179)

Phoenix Children's Hospital | Main - Transplant DepartmentPhoenix, Arizona, United StatesWithdrawn
Cedars-Sinai Samuel Oschin Cancer CenterLos Angeles, California, United StatesWithdrawn
Lucille Packard Children's Hospital Stanford - Pediatric NephrologyPalo Alto, California, United StatesRecruiting
Rady Children's Hospital San Diego - CardiologySan Diego, California, United StatesNot Yet Recruiting
Children's National Hospital - NephrologyWashington D.C., District of Columbia, United StatesNot Yet Recruiting
Memorial Transplant Institute - Pediatric NephrologyHollywood, Florida, United StatesNot Yet Recruiting
Emory University Hospital/Children's Healthcare of Atlanta - NephrologyAtlanta, Georgia, United StatesWithdrawn
University of Iowa Health Care Medical Center - NephrologyIowa City, Iowa, United StatesWithdrawn
The Charlotte R. Bloomberg Children's Center Building - NephrologyBaltimore, Maryland, United StatesRecruiting
Boston Children's Hospital - Main Campus - NephrologyBoston, Massachusetts, United StatesWithdrawn
Children's Mercy Hospital Kansas City - NephrologyKansas City, Missouri, United StatesNot Yet Recruiting
Cincinnati Children's Hospital Medical Center | Division of Nephrology and HypertensionCincinnati, Ohio, United StatesNot Yet Recruiting

+ 167 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05457283